Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Microt

Request full access

Micro-invasive implants for glaucoma treatment

Seoul, South KoreaFounded 2019Health Tech & Medtech

About Microt

Microt is a South Korean medical device company founded in 2019 that specializes in developing and manufacturing implants for glaucoma treatment. The company aims to provide safe and reliable treatment alternatives to assist medical staff and patients, addressing the world's second leading cause of blindness.

The company's main product is the A-stream® Glaucoma Shunt, a micro-invasive glaucoma surgery (MIGS) implant designed to control intraocular pressure (IOP). This device is a 6mm silicone tube with a 100µm inner diameter and a 1mm wing to hold it in place. It features a pre-placed ripcord that allows for adjustable flow control, aiming to reduce early hypotony and enable stepwise postoperative IOP adjustments. A short-term study showed that the A-stream shunt effectively lowered IOP with high success rates. Microt also offers Blecure MD Gel for dry and damaged periocular skin.

Since its establishment, Microt has achieved several milestones, including the completion of its Series A and B funding rounds. By July 2025, the company had raised a total of $13.7M. The company has received multiple accolades, including being selected as a "Baby Unicorn" company by the South Korean Ministry of SMEs and Startups. Its A-stream Glaucoma Shunt has received Korean MFDS (Ministry of Food and Drug Safety) approval and is approved for reimbursement under the Korean National Health Insurance. As of early 2025, the A-stream shunt had surpassed 1,500 surgical cases.

Microt operates in the surgical devices market and is headquartered in Seoul, South Korea. The company has formed research collaborations with institutions like KAIST, Sungkyunkwan University, and Chungbuk National University to advance its core technology. Its investors include Comes Investment, Horizon Investment, ID Ventures, Industrial Bank of Korea, and Samsung Medical Center.

Source: Dealroom company data

At a glance

Status
Operational
Employees
13
Open positions
1
Dealroom signal
40.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
Ophthalmology, medical implants, Surgery, Surgical Equipment, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jul 2025 $16M $62M Undisclosed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Microt website traffic

Latest recorded traffic for Microt is 4.1K monthly website visits, up 57.7% over the last three months.

Latest monthly visits4.1K 3-month web change+57.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Microt in the Seoul ecosystem

Live from Dealroom

The Microt office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Microt’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.